Collegium Pharmaceutical, Inc. (COLL) Operating cash flow 2016–2025
Collegium Pharmaceutical, Inc. (COLL) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$329.3MFY2025 · since FY2016: -$75.1M → $329.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $329.3M | +60.7% |
| FY2024 | $205.0M | -25.4% |
| FY2023 | $274.7M | +121.2% |
| FY2022 | $124.2M | +20.0% |
| FY2021 | $103.6M | +10.2% |
| FY2020 | $93.9M | +238.1% |
| FY2019 | $27.8M | -83.6% |
| FY2018 | $169.4M | +352.8% |
| FY2017 | -$67.0M | +10.7% |
| FY2016 | -$75.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice